OPEN END TURBO LONG - BECTON DICKINSON AND CO. Stock

Certificat

DE000MB7SK80

Real-time Bid/Ask 09:02:05 2024-06-17 am EDT
1.38 EUR / 1.55 EUR -2.98% Intraday chart for OPEN END TURBO LONG - BECTON DICKINSON AND CO.
Current month+10.22%
1 month-13.71%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-17 1.41 -6.62%
24-06-14 1.51 +11.85%
24-06-13 1.35 -16.67%
24-06-12 1.62 -10.99%
24-06-11 1.82 -12.50%

Delayed Quote Börse Stuttgart

Last update June 17, 2024 at 07:14 am EDT

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying BECTON, DICKINSON AND COMPANY
Issuer Morgan Stanley
WKN MB7SK8
ISINDE000MB7SK80
Date issued 2023-06-21
Strike 217.9 $
Maturity Unlimited
Parity 10 : 1
Emission price 5.44
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 7.69
Lowest since issue 0.63
Spread 0.22
Spread %13.50%

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
233.7 USD
Average target price
279.2 USD
Spread / Average Target
+19.45%
Consensus